XSES
E28
Market cap1.04bUSD
Jun 19, Last price
3.13SGD
1D
0.32%
1Q
50.48%
Jan 2017
1,204.17%
IPO
702.56%
Name
Frencken Group Ltd
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Frencken Group Limited functions as an investment holding company, offering comprehensive original design, original equipment, and integrated manufacturing solutions on a global scale. The company operates through two main divisions: The Mechatronics segment is dedicated to the design, development, and production of advanced precision-engineered systems, machinery, electromechanical assemblies, and high-accuracy parts. These products serve original equipment manufacturers (OEMs) in critical industries such as healthcare, analytical and life sciences, semiconductors, and industrial automation. Its services extend to value engineering, prototyping, specialized component machining, sheet metal fabrication, as well as the assembly, integration, testing, and commissioning of modular and complete equipment systems, complemented by research and development initiatives. The Integrated Manufacturing Services (IMS) segment delivers end-to-end contract design and manufacturing capabilities for the automotive, consumer, and industrial electronics sectors. This includes the design, engineering, manufacturing, and sale of filters; the production of molds, dies, plastic products, and component sub-assemblies; injection mold making and molding; the manufacturing and distribution of plastic goods; and the design and trade of micro-mechanical product components primarily for the automotive industry. Beyond these core manufacturing activities, Frencken Group also engages in property ownership and provides specialized services such as vacuum coating and thermal treatment for plastic components. The company was founded in 1995 and is headquartered in George Town, Malaysia.
Valuation
Title SGD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||